JHERX
Price
$19.85
Change
+$0.08 (+0.40%)
Updated
Jul 3 closing price
Net Assets
323.89M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

JHERX vs VVIAX

Header iconJHERX vs VVIAX Comparison
Open Charts JHERX vs VVIAXBanner chart's image
JHancock Equity Income C
Price$19.85
Change+$0.08 (+0.40%)
VolumeN/A
Net Assets323.89M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
JHERX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JHERX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHERX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. JHERX (324M). VVIAX pays higher dividends than JHERX: VVIAX (2.18) vs JHERX (0.95). JHERX was incepted earlier than VVIAX: JHERX (10 years) vs VVIAX (25 years). JHERX (1.84) is less costly to investors than VVIAX (0.05). JHERX is a more actively managed with annual turnover of: 22.00 vs. VVIAX (9.00). JHERX has a lower initial minimum investment than VVIAX: JHERX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. JHERX (0.32). VVIAX return over 5 years is better than : 80.13 vs. JHERX (33.53).
JHERXVVIAXJHERX / VVIAX
Total Expense Ratio1.830.053,660%
Annual Report Gross Expense Ratio1.840.053,680%
Fund Existence10 years25 years-
Gain YTD6.4426.198104%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets324M189B0%
Annual Yield % from dividends0.952.1844%
Returns for 1 year0.3212.033%
Returns for 3 years3.5835.1710%
Returns for 5 years33.5380.1342%
Returns for 10 years6.84115.676%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.